OBJECTIVES: Re-irradiation of recurrent intracranial meningiomas represents a major challenge due to dose limits of critical structures and the necessity of sufficient dose coverage of the recurrent tumor for local control. The aim of this study was to investigate dosimetric differences between pencil beam scanning protons (PBS) and volumetric modulated arc therapy (VMAT) photons for intracranial re-irradiation of meningiomas. METHODS: Nine patients who received an initial dose >50 Gy for intracranial meningioma and who were re-irradiated for recurrence were selected for plan comparison. A volumetric modulated arc therapy photon and a pencil beam scanning proton plan were generated (prescription dose: 15 × 3 Gy) based on the targets used in the re-irradiation treatment. RESULTS: In all cases, where the cumulative dose exceeded 100 or 90 Gy, these high dose volumes were larger for the proton plans. The integral doses were significantly higher in all photon plans (reduction with protons: 48.6%, p < 0.01). In two cases (22.2%), organ at risk (OAR) sparing was superior with the proton plan. In one case (11.1%), the photon plan showed a dosimetric advantage. In the remaining six cases (66.7%), we found no clinically relevant differences in dose to the OARs. CONCLUSIONS: The dosimetric results of the accumulated dose for a re-irradiation with protons and with photons were very similar. The photon plans had a steeper dose falloff directly outside the target and were superior in minimizing the high dose volumes. The proton plans achieved a lower integral dose. Clinically relevant OAR sparing was extremely case specific. The optimal treatment modality should be assessed individually. ADVANCES IN KNOWLEDGE: Dose sparing in re-irradiation of intracranial meningiomas with protons or photons is highly case specific and the optimal treatment modality needs to be assessed on an individual basis.
OBJECTIVES: Re-irradiation of recurrent intracranial meningiomas represents a major challenge due to dose limits of critical structures and the necessity of sufficient dose coverage of the recurrent tumor for local control. The aim of this study was to investigate dosimetric differences between pencil beam scanning protons (PBS) and volumetric modulated arc therapy (VMAT) photons for intracranial re-irradiation of meningiomas. METHODS: Nine patients who received an initial dose >50 Gy for intracranial meningioma and who were re-irradiated for recurrence were selected for plan comparison. A volumetric modulated arc therapy photon and a pencil beam scanning proton plan were generated (prescription dose: 15 × 3 Gy) based on the targets used in the re-irradiation treatment. RESULTS: In all cases, where the cumulative dose exceeded 100 or 90 Gy, these high dose volumes were larger for the proton plans. The integral doses were significantly higher in all photon plans (reduction with protons: 48.6%, p < 0.01). In two cases (22.2%), organ at risk (OAR) sparing was superior with the proton plan. In one case (11.1%), the photon plan showed a dosimetric advantage. In the remaining six cases (66.7%), we found no clinically relevant differences in dose to the OARs. CONCLUSIONS: The dosimetric results of the accumulated dose for a re-irradiation with protons and with photons were very similar. The photon plans had a steeper dose falloff directly outside the target and were superior in minimizing the high dose volumes. The proton plans achieved a lower integral dose. Clinically relevant OAR sparing was extremely case specific. The optimal treatment modality should be assessed individually. ADVANCES IN KNOWLEDGE: Dose sparing in re-irradiation of intracranial meningiomas with protons or photons is highly case specific and the optimal treatment modality needs to be assessed on an individual basis.
Authors: Søren M Bentzen; Louis S Constine; Joseph O Deasy; Avi Eisbruch; Andrew Jackson; Lawrence B Marks; Randall K Ten Haken; Ellen D Yorke Journal: Int J Radiat Oncol Biol Phys Date: 2010-03-01 Impact factor: 7.038
Authors: P M Teo; S F Leung; A T Chan; T W Leung; P H Choi; W H Kwan; W Y Lee; R M Chau; P K Yu; P J Johnson Journal: Int J Radiat Oncol Biol Phys Date: 2000-12-01 Impact factor: 7.038
Authors: Hann-Hsiang Chao; Abigail T Berman; Charles B Simone; Christine Ciunci; Peter Gabriel; Haibo Lin; Stefan Both; Corey Langer; Kristi Lelionis; Ramesh Rengan; Stephen M Hahn; Kiran Prabhu; Marcio Fagundes; William Hartsell; Rosemarie Mick; John P Plastaras Journal: J Thorac Oncol Date: 2016-11-05 Impact factor: 15.609
Authors: Felix Scholtyssek; Isabella Zwiener; Annika Schlamann; Clemens Seidel; Jürgen Meixensberger; Manfred Bauer; Karl-Titus Hoffmann; Stephanie E Combs; André O von Bueren; Rolf-Dieter Kortmann; Klaus Müller Journal: Radiat Oncol Date: 2013-07-03 Impact factor: 3.481
Authors: Samuel Ryu; John M Buatti; Ann Morris; Steven N Kalkanis; Timothy Charles Ryken; Jeffrey J Olson Journal: J Neurooncol Date: 2014-04-12 Impact factor: 4.130
Authors: Maria Jesus Lobón; Francisco Bautista; François Riet; Frederic Dhermain; Sandra Canale; Christelle Dufour; Thomas Blauwblomme; Michel Zerah; Kevin Beccaria; Christian Saint-Rose; Stephanie Puget; Christian Carrie; Eric Lartigau; Pierre-Yves Bondiau; Dominique Valteau-Couanet; Jacques Grill; Stephanie Bolle Journal: Springerplus Date: 2016-06-24
Authors: Indrawati Hadi; Annamaria Biczok; Nicole Terpolilli; Jun Thorsteinsdottir; Robert Forbrig; Nathalie L Albert; Petar Yanchovski; Barbara Zollner; Raphael Bodensohn; Stefanie Corradini; Peter Bartenstein; Claus Belka; Jörg-Christian Tonn; Christian Schichor; Maximilian Niyazi Journal: Neurooncol Adv Date: 2021-08-20